RISalud
Institutional Health Repository of Andalucía
Browsing by Author Felip, Enriqueta
Showing results 1 to 19 of 19
| Preview | Title | Author(s) | Issue Date |
|---|---|---|---|
| A Delphi consensus panel about clinical management of early-stage EGFR-mutated non-small cell lung cancer (NSCLC) in Spain: a Delphi consensus panel study. | Isla, Dolores; Felip, Enriqueta; Garrido, Pilar; Insa, Amelia; Majem, Margarita; Remon, Jordi; Trigo, Jose M; de Castro, Javier | 27-Sep-2022 | |
| Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung: Final analysis of the randomised phase 3 LUX-Lung 8 trial. | Goss, Glenwood D; Cobo, Manuel; Lu, Shun; Syrigos, Konstantinos; Lee, Ki Hyeong; Göker, Erdem; Georgoulias, Vassilis; Isla, Dolores; Morabito, Alessandro; Min, Young J; Ardizzoni, Andrea; Bender, Shaun; Cseh, Agnieszka; Felip, Enriqueta | 18-Jun-2021 | |
| Alectinib for the treatment of pretreated RET-rearranged advanced NSCLC: Results of the ETOP ALERT-lung trial. | Felip, Enriqueta; Smit, Egbert F; Molina-Vila, Miguel A; Dafni, Urania; Massuti, Bartomeu; Berghmans, Thierry; de Marinis, Filippo; Passiglia, Francesco; Dingemans, Anne-Marie C; Cobo, Manuel; Viteri, Santiago; Britschgi, Christian; Cuffe, Sinead; Provencio, Mariano; Merkelbach-Bruse, Sabine; Andriakopoulou, Charitini; Kammler, Roswitha; Ruepp, Barbara; Roschitzki-Voser, Heidi; Peters, Solange; Wolf, Jürgen; Stahel, Rolf; ETOP 12-17 ALERT-lung Collaborators | 12-Aug-2022 | |
| Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non-Small Cell Lung Carcinoma: the ROSING Study. | Conde, Esther; Hernandez, Susana; Martinez, Rebeca; Angulo, Barbara; De Castro, Javier; Collazo-Lorduy, Ana; Jimenez, Beatriz; Muriel, Alfonso; Mate, Jose Luis; Moran, Teresa; Aranda, Ignacio; Massuti, Bartomeu; Rojo, Federico; Domine, Manuel; Sansano, Irene; Garcia, Felip; Felip, Enriqueta; Mancheño, Nuria; Juan, Oscar; Sanz, Julian; Gonzalez-Larriba, Jose Luis; Atienza-Cuevas, Lidia; Arriola-Arellano, Esperanza; Abdulkader, Ihab; Garcia-Gonzalez, Jorge; Camacho, Carmen; Rodriguez-Abreu, Delvys; Teixido, Cristina; Reguart, Noemi; Gonzalez-Piñeiro, Ana; Lazaro-Quintela, Martin; Lozano, Maria Dolores; Gurpide, Alfonso; Gomez-Roman, Javier; Lopez-Brea, Marta; Pijuan, Lara; Salido, Marta; Arriola, Edurne; Company, Amparo; Insa, Amelia; Esteban-Rodriguez, Isabel; Saiz, Monica; Azkona, Eider; Alvarez, Ramiro; Artal, Angel; Plaza, Maria Luz; Aguiar, David; Enguita, Ana Belen; Benito, Amparo; Paz-Ares, Luis; Garrido, Pilar; Lopez-Rios, Fernando | 23-Jul-2019 | |
| Association of ERBB Mutations With Clinical Outcomes of Afatinib- or Erlotinib-Treated Patients With Lung Squamous Cell Carcinoma: Secondary Analysis of the LUX-Lung 8 Randomized Clinical Trial. | Goss, Glenwood D; Felip, Enriqueta; Cobo, Manuel; Lu, Shun; Syrigos, Konstantinos; Lee, Ki Hyeong; Göker, Erdem; Georgoulias, Vassilis; Li, Wei; Guclu, Salih; Isla, Dolores; Min, Young Joo; Morabito, Alessandro; Ardizzoni, Andrea; Gadgeel, Shirish M; Fülöp, Andrea; Bühnemann, Claudia; Gibson, Neil; Krämer, Nicole; Solca, Flavio; Cseh, Agnieszka; Ehrnrooth, Eva; Soria, Jean-Charles | 2018 | |
| Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trial. | Peters, Solange; Dziadziuszko, Rafal; Morabito, Alessandro; Felip, Enriqueta; Gadgeel, Shirish M; Cheema, Parneet; Cobo, Manuel; Andric, Zoran; Barrios, Carlos H; Yamaguchi, Masafumi; Dansin, Eric; Danchaivijitr, Pongwut; Johnson, Melissa; Novello, Silvia; Mathisen, Michael S; Shagan, Sarah M; Schleifman, Erica; Wang, Jin; Yan, Mark; Mocci, Simonetta; Voong, David; Fabrizio, David A; Shames, David S; Riehl, Todd; Gandara, David R; Mok, Tony | 22-Aug-2022 | |
| Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Second-Line Treatment of Patients With NSCLC: Results From an Expansion Cohort of a Phase 1 Trial. | Paz-Ares, Luis; Kim, Tae Min; Vicente, David; Felip, Enriqueta; Lee, Dae Ho; Lee, Ki Hyeong; Lin, Chia-Chi; Flor, Maria Jose; Di Nicola, Massimo; Alvarez, Rosa Maria; Dussault, Isabelle; Helwig, Christoph; Ojalvo, Laureen S; Gulley, James L; Cho, Byoung Chul | 13-Mar-2020 | |
| CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations. | Felip, Enriqueta; Ardizzoni, Andrea; Ciuleanu, Tudor; Cobo, Manuel; Laktionov, Konstantin; Szilasi, Maria; Califano, Raffaele; Carcereny, Enric; Griffiths, Richard; Paz-Ares, Luis; Duchnowska, Renata; Garcia, Miriam Alonso; Isla, Dolores; Jassem, Jacek; Appel, Wiebke; Milanowski, Janusz; Van Meerbeeck, Jan P; Wolf, Juergen; Li, Ang; Acevedo, Angelic; Popat, Sanjay | 3-Feb-2020 | |
| Economic Analysis of First-Line Treatment with Erlotinib in an EGFR-Mutated Population with Advanced NSCLC. | Vergnenegre, Alain; Massuti, Bartomeu; de Marinis, Filippo; Carcereny, Enric; Felip, Enriqueta; Do, Pascal; Sanchez, Jose Miguel; Paz-Arez, Luis; Chouaid, Christos; Rosell, Rafael; Spanish Lung Cancer Group, Italian Association of Thoracic Oncology, and French Lung Cancer Group | 18-Feb-2016 | |
| Evaluation of the VeriStrat® serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 study. | Gadgeel, Shirish; Goss, Glenwood; Soria, Jean-Charles; Felip, Enriqueta; Georgoulias, Vassilis; Lu, Shun; Cobo, Manuel; Syrigos, Konstantinos; Lee, Ki Hyeong; Göker, Erdem; Guclu, Salih Z; Isla, Dolores; Morabito, Alessandro; Dupuis, Nicholas; Bühnemann, Claudia; Krämer, Nicole; Solca, Flavio; Ehrnrooth, Eva; Ardizzoni, Andrea | 11-May-2017 | |
| Final Overall Survival and Other Efficacy and Safety Results From ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged NSCLC. | Nishio, Makoto; Felip, Enriqueta; Orlov, Sergey; Park, Keunchil; Yu, Chong-Jen; Tsai, Chun-Ming; Cobo, Manuel; McKeage, Mark; Su, Wu-Chou; Mok, Tony; Scagliotti, Giorgio V; Spigel, David R; Viraswami-Appanna, Kalyanee; Chen, Zhe; Passos, Vanessa Q; Shaw, Alice T | 25-Nov-2019 | |
| First-in-human, open-label, phase 1/2 study of the monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor cetrelimab (JNJ-63723283) in patients with advanced cancers. | Felip, Enriqueta; Moreno, Victor; Morgensztern, Daniel; Curigliano, Giuseppe; Rutkowski, Piotr; Trigo, José Manuel; Calvo, Aitana; Kowalski, Dariusz; Cortinovis, Diego; Plummer, Ruth; Maio, Michele; Ascierto, Paolo A; Vladimirov, Vladimir I; Cervantes, Andres; Zudaire, Enrique; Hazra, Anasuya; T'jollyn, Huybrecht; Bandyopadhyay, Nibedita; Greger, James G; Attiyeh, Edward; Xie, Hong; Calvo, Emiliano | 17-Mar-2022 | |
| Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer. | Borghaei, Hossein; Gettinger, Scott; Vokes, Everett E; Chow, Laura Q M; Burgio, Marco Angelo; de Castro Carpeno, Javier; Pluzanski, Adam; Arrieta, Oscar; Frontera, Osvaldo Arén; Chiari, Rita; Butts, Charles; Wójcik-Tomaszewska, Joanna; Coudert, Bruno; Garassino, Marina Chiara; Ready, Neal; Felip, Enriqueta; García, Miriam Alonso; Waterhouse, David; Domine, Manuel; Barlesi, Fabrice; Antonia, Scott; Wohlleber, Markus; Gerber, David E; Czyzewicz, Grzegorz; Spigel, David R; Crino, Lucio; Eberhardt, Wilfried Enst Erich; Li, Ang; Marimuthu, Sathiya; Brahmer, Julie | 15-Jan-2021 | |
| Lung Cancer in Women with a Family History of Cancer: The Spanish Female-specific Database WORLD07. | Isla, Dolores; Felip, Enriqueta; Viñolas, Nuria; Provencio, Mariano; Majem, Margarita; Artal, Angel; Bover, Isabel; Lianes, Pilar; DE Las Peñas, Ramón; Catot, Silvia; DE Castro, Javier; Blasco, Ana; Terrasa, Josefa; Gonzalez-Larriba, José Luis; Juan, Oscar; Dómine, Manuel; Bernabe, Reyes; Garrido, Pilar | 2016 | |
| LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology. | Garrido, Pilar; Paz-Ares, Luis; Majem, Margarita; Morán, Teresa; Trigo, José Manuel; Bosch-Barrera, Joaquim; Garcίa-Campelo, Rosario; González-Larriba, José Luis; Sánchez-Torres, José Miguel; Isla, Dolores; Viñolas, Núria; Camps, Carlos; Insa, Amelia; Juan, Óscar; Massuti, Bartomeu; Paredes, Alfredo; Artal, Ángel; López-Brea, Marta; Palacios, José; Felip, Enriqueta | 23-Jul-2021 | |
| Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057). | Horn, Leora; Spigel, David R; Vokes, Everett E; Holgado, Esther; Ready, Neal; Steins, Martin; Poddubskaya, Elena; Borghaei, Hossein; Felip, Enriqueta; Paz-Ares, Luis; Pluzanski, Adam; Reckamp, Karen L; Burgio, Marco A; Kohlhäeufl, Martin; Waterhouse, David; Barlesi, Fabrice; Antonia, Scott; Arrieta, Oscar; Fayette, Jérôme; Crinò, Lucio; Rizvi, Naiyer; Reck, Martin; Hellmann, Matthew D; Geese, William J; Li, Ang; Blackwood-Chirchir, Anne; Healey, Diane; Brahmer, Julie; Eberhardt, Wilfried E E | 12-Oct-2017 | |
| Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung Cancer. | Sequist, Lecia V; Gray, Jhanelle Elaine; Harb, Wael A; Lopez-Chavez, Ariel; Doebele, Robert C; Modiano, Manuel R; Jackman, David Michael; Baggstrom, Maria Quintos; Atmaca, Akin; Felip, Enriqueta; Provencio, Mariano; Cobo, Manuel; Adiwijaya, Bambang; Kuesters, Geoffrey; Kamoun, Walid S; Andreas, Karen; Pipas, J Marc; Santillana, Sergio; Cho, Byoung Chul; Park, Keunchil; Shepherd, Frances A | 11-Apr-2019 | |
| Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical Trial. | Michels, Sebastian; Massutí, Bartomeu; Schildhaus, Hans-Ulrich; Franklin, Jeremy; Sebastian, Martin; Felip, Enriqueta; Grohé, Christian; Rodriguez-Abreu, Delvys; Abdulla, Diana S Y; Bischoff, Helge; Brandts, Christian; Carcereny, Enric; Corral, Jesús; Dingemans, Anne-Marie C; Pereira, Eva; Fassunke, Jana; Fischer, Rieke N; Gardizi, Masyar; Heukamp, Lukas; Insa, Amelia; Kron, Anna; Menon, Roopika; Persigehl, Thorsten; Reck, Martin; Riedel, Richard; Rothschild, Sacha I; Scheel, Andreas H; Scheffler, Matthias; Schmalz, Petra; Smit, Egbert F; Limburg, Meike; Provencio, Mariano; Karachaliou, Niki; Merkelbach-Bruse, Sabine; Hellmich, Martin; Nogova, Lucia; Büttner, Reinhard; Rosell, Rafael; Wolf, Jürgen | 9-Apr-2019 | |
| Symptom and Quality of Life Improvement in LUX-Lung 8, an Open-Label Phase III Study of Second-Line Afatinib Versus Erlotinib in Patients With Advanced Squamous Cell Carcinoma of the Lung After First-Line Platinum-Based Chemotherapy. | Felip, Enriqueta; Hirsh, Vera; Popat, Sanjay; Cobo, Manuel; Fülöp, Andrea; Dayen, Charles; Trigo, José M; Gregg, Richard; Waller, Cornelius F; Soria, Jean-Charles; Goss, Glenwood D; Gordon, James; Wang, Bushi; Palmer, Michael; Ehrnrooth, Eva; Gadgeel, Shirish M | 23-Jun-2017 |